RxDoctor Payments Data

Keith Fehring, MD

Orthopaedic Surgery · Charlotte, NCNPI 1861629149

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (50.3%), royalties or licence payments and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 43.8% of the total. Among orthopaedic surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$664,758in general payments, 2019–2025

Across 404 payments — averaging $1645.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$291K
  • Medical Device Business Services, Inc.$271K
  • Zimmer Biomet$99K
  • Arthrex$1K
  • Johnson & Johnson$594
  • Smith+Nephew$497
  • plus $2K from 12 others
$14,100in research payments, 2019–2025

Across 29 payments — averaging $486.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$14K

What the payments were for

  • Royalty or licence$254,98138%
  • Consulting fees$334,25650%
  • Travel & lodging$25,8444%
  • Food & beverage$11,8272%
  • Education$37,8506%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$664,758 in reported general payments places this provider in the 95th percentile of 845 orthopaedic surgery providers in North Carolina.

See all orthopaedic surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$359,242
Medicare patients
479
Services billed
1,810

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam255$544
Doxycycline Hyclate23$383
Diclofenac Sodium21$373
Methylprednisolone55$320
Tramadol Hcl49$202
Celecoxib14$180
Oxycodone Hcl22$112
Ondansetron Hcl14$76
Amoxicillin90$76
Gabapentin12$60
Clindamycin Hcl19$28

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →